Severe infection, rituximab use predict long COVID in patients with autoimmune disease
WASHINGTON — Severe acute COVID-19 infection, as well as glucocorticoid and rituximab use, increase the risk for long COVID in patients with autoimmune rheumatic diseases, according to data presented at ACR Convergence 2024. “We know from the work of several people from the height of the pandemic that autoimmune rheumatic disease patients were at higher risk of severe outcomes from